GOING BEYOND EVERY DAY Trademark

Trademark Overview


On Thursday, February 2, 2023, a trademark application was filed for GOING BEYOND EVERY DAY with the United States Patent and Trademark Office. The USPTO has given the GOING BEYOND EVERY DAY trademark a serial number of 97778742. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Friday, June 28, 2024. This trademark is owned by Ultragenyx Pharmaceutical Inc.. The GOING BEYOND EVERY DAY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the field of gene therapy manufacturing technology; biomedical and scientific research in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic diseases, gene therapy, and cell therapy biomedical research in the field of gene therapy design and delivery; gene therapy research, namely, design and delivery development of biochemical assays; product development in the fields of genetic therapies and effectors to regulate, modulate, and characterize disease states; pharmaceutical research and development in the field of gene therapy; scientific, medical, and pharmaceutical research in the nature of conducting clinical trials for others in the field of gene therapy design and delivery; medical and scientific research, namely, compiling and sharing of patient data for research purposes in the field of rare diseases and disorders; providing medical and scientific research information in the field of rare diseases and disorder
going beyond every day

General Information


Serial Number97778742
Word MarkGOING BEYOND EVERY DAY
Filing DateThursday, February 2, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateFriday, June 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 28, 2023

Trademark Statements


Goods and ServicesResearch and development in the field of gene therapy manufacturing technology; biomedical and scientific research in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic diseases, gene therapy, and cell therapy biomedical research in the field of gene therapy design and delivery; gene therapy research, namely, design and delivery development of biochemical assays; product development in the fields of genetic therapies and effectors to regulate, modulate, and characterize disease states; pharmaceutical research and development in the field of gene therapy; scientific, medical, and pharmaceutical research in the nature of conducting clinical trials for others in the field of gene therapy design and delivery; medical and scientific research, namely, compiling and sharing of patient data for research purposes in the field of rare diseases and disorders; providing medical and scientific research information in the field of rare diseases and disorder

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, February 9, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameUltragenyx Pharmaceutical Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNovato, CA 94949

Party NameUltragenyx Pharmaceutical Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNovato, CA 94949

Trademark Events


Event DateEvent Description
Thursday, February 9, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 7, 2023NEW APPLICATION ENTERED
Thursday, September 21, 2023ASSIGNED TO EXAMINER
Thursday, October 5, 2023NON-FINAL ACTION WRITTEN
Thursday, October 5, 2023NON-FINAL ACTION E-MAILED
Thursday, October 5, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 23, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 23, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 24, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 24, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 28, 2023PUBLISHED FOR OPPOSITION
Tuesday, November 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, June 28, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, January 23, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, June 28, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 28, 2024SOU EXTENSION 1 FILED
Friday, August 2, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 2, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 2, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, August 2, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 28, 2024SOU EXTENSION 1 GRANTED